TL;DR: Reid Hoffman is stepping down from Microsoft's board to focus on his AI drug discovery startup Manus, highlighting a high-profile shift to early-stage biotech AI.
Summary: Reid Hoffman has announced his departure from Microsoft's board of directors after a decade of service. He is stepping down to focus on Manus, an AI-driven drug discovery startup. The move allows Hoffman to transition to 'founder mode' to lead the biotech startup's development.
Why it matters: This transition signals a growing concentration of top-tier tech talent and capital into specialized AI applications like biotechnology. Developers should monitor how Manus leverages machine learning to accelerate drug discovery pipelines.
Source: feeds.feedburner.com